ZA923321B - Recombinant avipox virus,the culture of cells infected by this virus and vaccines for poultry derived from this virus - Google Patents
Recombinant avipox virus,the culture of cells infected by this virus and vaccines for poultry derived from this virusInfo
- Publication number
- ZA923321B ZA923321B ZA923321A ZA923321A ZA923321B ZA 923321 B ZA923321 B ZA 923321B ZA 923321 A ZA923321 A ZA 923321A ZA 923321 A ZA923321 A ZA 923321A ZA 923321 B ZA923321 B ZA 923321B
- Authority
- ZA
- South Africa
- Prior art keywords
- virus
- vaccines
- culture
- cells infected
- recombinant avipox
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title 2
- 241000700663 Avipoxvirus Species 0.000 title 1
- 244000144977 poultry Species 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/455—Eimeria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24041—Use of virus, viral particle or viral elements as a vector
- C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BE9100507A BE1004877A3 (en) | 1991-05-27 | 1991-05-27 | RECOMBINANT AVIPOX VIRUS, CULTURE OF CELLS INFECTED WITH THIS VIRUS AND POULTRY VACCINES DERIVED FROM THIS VIRUS. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA923321B true ZA923321B (en) | 1993-01-27 |
Family
ID=3885526
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA923321A ZA923321B (en) | 1991-05-27 | 1992-05-07 | Recombinant avipox virus,the culture of cells infected by this virus and vaccines for poultry derived from this virus |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP0517292B1 (en) |
| JP (1) | JP3411307B2 (en) |
| KR (1) | KR100244601B1 (en) |
| CN (1) | CN1055501C (en) |
| AR (1) | AR248045A1 (en) |
| AT (1) | ATE189480T1 (en) |
| AU (1) | AU656185B2 (en) |
| BE (1) | BE1004877A3 (en) |
| BR (1) | BR9202024A (en) |
| CA (1) | CA2069594A1 (en) |
| DE (1) | DE69230627T2 (en) |
| DK (1) | DK0517292T3 (en) |
| ES (1) | ES2145000T3 (en) |
| HU (1) | HU215531B (en) |
| IE (1) | IE921686A1 (en) |
| IL (1) | IL101780A (en) |
| MX (1) | MX9202512A (en) |
| NZ (1) | NZ242620A (en) |
| PT (1) | PT517292E (en) |
| RU (1) | RU2130971C1 (en) |
| SG (1) | SG49876A1 (en) |
| TW (1) | TW288048B (en) |
| ZA (1) | ZA923321B (en) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0597016A4 (en) * | 1991-07-26 | 1996-04-24 | Virogenetics Corp | Infectious bursal disease virus recombinant poxvirus vaccine. |
| PT623172E (en) * | 1992-01-13 | 2005-02-28 | Virogenetics Corp | RECOMBINANT VACCINIA VIRUS FROM MAREK'S DISEASE VIRUS |
| FR2697534A1 (en) * | 1992-11-02 | 1994-05-06 | Rhone Merieux | Recombinant turkey herpes virus for the production of Gumboro disease vaccine, its preparation process and vaccine obtained. |
| US5925358A (en) * | 1993-02-26 | 1999-07-20 | Syntro Corporation | Recombinant fowlpox viruses and uses thereof |
| EP0696204A4 (en) * | 1993-02-26 | 1999-03-31 | Syntro Corp | Recombinant fowlpox viruses and uses thereof |
| US6136318A (en) * | 1993-02-26 | 2000-10-24 | Cochran; Mark D. | Recombinant fowlpox viruses and uses thereof |
| FR2728794B1 (en) * | 1994-12-30 | 1997-03-21 | Rhone Merieux | AVIAN RECOMBINANT VACCINE BASED ON AVIAN HERPES VIRUS, PARTICULARLY AGAINST GUMBORO DISEASE |
| FR2728795B1 (en) * | 1994-12-30 | 1997-03-21 | Rhone Merieux | AVIAN RECOMBINANT LIVING VACCINE USING AVIAN HERPES VIRUS AS A VECTOR |
| GB9711957D0 (en) | 1997-06-09 | 1997-08-06 | Isis Innovation | Methods and reagents for vaccination |
| GB0118532D0 (en) | 2001-07-30 | 2001-09-19 | Isis Innovation | Materials and methods relating to improved vaccination strategies |
| GB2382578A (en) * | 2001-11-30 | 2003-06-04 | Isis Innovation | Fowlpox-based vaccine |
| CN1596126A (en) | 2001-11-30 | 2005-03-16 | 埃西斯创新有限公司 | Vaccine |
| SI1407033T1 (en) * | 2002-05-16 | 2006-06-30 | Bavarian Nordic As | Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva) |
| EP1601333B1 (en) * | 2003-02-20 | 2013-01-23 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services | Novel insertion sites in pox vectors |
| GB2402391A (en) * | 2003-06-04 | 2004-12-08 | Oxxon Pharmaccines Ltd | Fowlpox recombinant genome |
| HRP20190525T8 (en) | 2011-11-30 | 2023-01-20 | Boehringer Ingelheim Animal Health USA Inc. | Recombinant gallid herpesvirus 3 (mdv serotype 2) vectors expressing antigens of avian pathogens and uses thereof |
| EP2845904A1 (en) | 2013-09-06 | 2015-03-11 | Ceva Sante Animale | Recombinant Marek's disease viruses and uses thereof |
| EP3050572A1 (en) | 2015-01-29 | 2016-08-03 | Ceva Sante Animale | Recombinant MDV1 and the uses thereof |
| EP3263129A1 (en) | 2016-06-29 | 2018-01-03 | Ceva Sante Animale | Duck enteritis virus and the uses thereof |
| PE20191701A1 (en) | 2016-12-14 | 2019-11-27 | Boehringer Ingelheim Animal Health Usa Inc | RECOMBINANT VECTORS OF HVT EXPRESSING MULTIPLE ANTIGENS OF BIRD PATHOGENS AND THEIR USES |
| WO2020136220A1 (en) | 2018-12-27 | 2020-07-02 | Ceva Sante Animale | Recombinant viruses and the uses thereof |
| EP4168043A1 (en) | 2020-06-17 | 2023-04-26 | Boehringer Ingelheim Vetmedica GmbH | Recombinant hvt vectors expressing influenza hemagglutinin and immunogenic compositions, and production and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1988002022A1 (en) * | 1986-09-22 | 1988-03-24 | Commonwealth Scientific And Industrial Research Or | Recombinant poxviruses |
| FR2632863B2 (en) * | 1987-10-29 | 1990-08-31 | Transgene Sa | RECOMBINANT FOWLPOX VIRUS AND VACCINES DERIVED FROM SUCH VIRUSES |
| GB2220941B (en) * | 1988-06-24 | 1991-09-11 | Nat Res Dev | Fowlpox virus non-essential regions |
| AU623476B2 (en) * | 1988-12-29 | 1992-05-14 | Nippon Zeon Co., Ltd. | Promoter, plasmid containing the same, and recombinant avipoxvirus |
| WO1990015140A1 (en) * | 1989-05-30 | 1990-12-13 | Commonwealth Scientific And Industrial Research Organisation | Production of ibdv vp2 in highly immunogenic form |
-
1991
- 1991-05-27 BE BE9100507A patent/BE1004877A3/en not_active Expired - Lifetime
-
1992
- 1992-03-19 SG SG9608014A patent/SG49876A1/en unknown
- 1992-05-05 IL IL10178092A patent/IL101780A/en active IP Right Grant
- 1992-05-06 TW TW081103546A patent/TW288048B/zh active
- 1992-05-06 NZ NZ242620A patent/NZ242620A/en unknown
- 1992-05-07 ZA ZA923321A patent/ZA923321B/en unknown
- 1992-05-18 AU AU16323/92A patent/AU656185B2/en not_active Ceased
- 1992-05-19 DE DE69230627T patent/DE69230627T2/en not_active Expired - Fee Related
- 1992-05-19 AT AT92201406T patent/ATE189480T1/en not_active IP Right Cessation
- 1992-05-19 EP EP92201406A patent/EP0517292B1/en not_active Expired - Lifetime
- 1992-05-19 DK DK92201406T patent/DK0517292T3/en active
- 1992-05-19 ES ES92201406T patent/ES2145000T3/en not_active Expired - Lifetime
- 1992-05-19 PT PT92201406T patent/PT517292E/en unknown
- 1992-05-26 CA CA002069594A patent/CA2069594A1/en not_active Abandoned
- 1992-05-26 HU HU9201746A patent/HU215531B/en not_active IP Right Cessation
- 1992-05-26 AR AR92322400A patent/AR248045A1/en active
- 1992-05-27 JP JP13533192A patent/JP3411307B2/en not_active Expired - Fee Related
- 1992-05-27 RU SU5052222A patent/RU2130971C1/en active
- 1992-05-27 BR BR929202024A patent/BR9202024A/en not_active Application Discontinuation
- 1992-05-27 KR KR1019920009005A patent/KR100244601B1/en not_active IP Right Cessation
- 1992-05-27 CN CN92105030A patent/CN1055501C/en not_active Expired - Fee Related
- 1992-05-27 MX MX9202512A patent/MX9202512A/en unknown
- 1992-07-01 IE IE168692A patent/IE921686A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1069068A (en) | 1993-02-17 |
| DE69230627T2 (en) | 2000-09-28 |
| JP3411307B2 (en) | 2003-05-26 |
| DK0517292T3 (en) | 2000-05-08 |
| BE1004877A3 (en) | 1993-02-16 |
| CN1055501C (en) | 2000-08-16 |
| CA2069594A1 (en) | 1992-11-28 |
| ES2145000T3 (en) | 2000-07-01 |
| EP0517292A1 (en) | 1992-12-09 |
| IL101780A0 (en) | 1992-12-30 |
| JPH05244939A (en) | 1993-09-24 |
| HU215531B (en) | 2000-05-28 |
| KR100244601B1 (en) | 2000-03-02 |
| HUT62331A (en) | 1993-04-28 |
| PT517292E (en) | 2000-06-30 |
| RU2130971C1 (en) | 1999-05-27 |
| MX9202512A (en) | 1995-01-31 |
| DE69230627D1 (en) | 2000-03-09 |
| AU1632392A (en) | 1992-12-03 |
| AU656185B2 (en) | 1995-01-27 |
| KR920021706A (en) | 1992-12-18 |
| TW288048B (en) | 1996-10-11 |
| HU9201746D0 (en) | 1992-08-28 |
| IE921686A1 (en) | 1992-12-02 |
| SG49876A1 (en) | 2002-04-16 |
| EP0517292B1 (en) | 2000-02-02 |
| NZ242620A (en) | 1993-09-27 |
| AR248045A1 (en) | 1995-05-31 |
| BR9202024A (en) | 1993-01-19 |
| ATE189480T1 (en) | 2000-02-15 |
| IL101780A (en) | 2000-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA923321B (en) | Recombinant avipox virus,the culture of cells infected by this virus and vaccines for poultry derived from this virus | |
| AU2445888A (en) | Recombinant fowlpox virus, vectors for the expression of heterologous proteins and vaccines for poultry derived from this virus | |
| DE69016956D1 (en) | Recombinant turkey herpes virus and derived live vaccine vector. | |
| NO892251L (en) | PROCEDURE FOR THE PREPARATION OF COCOCOIDOSE VACCINE BY RECOMBINANT TECHNIQUES. | |
| ZA826154B (en) | Infectious bronchitis vaccines for poultry, process for the preparation of such vaccines, process for preventing infectious broachitis and infectious bronchitis virus strain | |
| GB2246784A (en) | Herpes virus recombinant poxvirus vaccine | |
| PT1403375E (en) | Recombinant live vaccine, using avian herpes virus as vector | |
| HK153395A (en) | Processor for the production of hcmv glycoproteins,antibodies thereto and hcmv vaccines and recombinant vectors therefor | |
| CA2186044A1 (en) | Novel mutated viruses, anti-viral compounds and novel methods of making vaccines | |
| AU7501898A (en) | Live attenuated virus vaccines for equine encephalitis viruses | |
| KR970009347B1 (en) | Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3 | |
| FR2620459B1 (en) | RECOMBINANT VACCINE VIRUS | |
| EP0597016A4 (en) | Infectious bursal disease virus recombinant poxvirus vaccine. | |
| GB2264949B (en) | Measles virus recombinant poxvirus vaccine | |
| EP0518313A3 (en) | Gene of hepatitis c virus or fragment thereof, polypeptide encoded by the same | |
| AU4090393A (en) | Fowl mycoplasma antigen, gene thereof, recombinant vector containing said gene, and vaccine prepared by utilizing the same | |
| AU6358190A (en) | Polypeptide vaccines against foot-and-mouth disease virus | |
| WO1997003187A3 (en) | Marek's disease virus genes and their use in vaccines for protection against marek's disease | |
| ZA908189B (en) | Infectious bronchitis virus vaccine | |
| EP0198828A4 (en) | Infectious bursal disease virus vaccine. | |
| WO1992014818A3 (en) | Entomopoxvirus expression system comprising spheroidin or thymidine-kinase sequences | |
| ZA919198B (en) | Measles virus recombinant poxvirus vaccine | |
| AU3748785A (en) | Infectious bursal disease virus vaccine | |
| AU6051396A (en) | Measles virus recombinant poxvirus vaccine | |
| GR3003377T3 (en) | Virus vaccine |